◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › K › KDH

Thonburi Medical Centre Public Company Limited (KDH) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Care Facilities · DATA UPDATED 2026-08-22

Thonburi Medical Centre Public Company Limited (KDH) operates in the Medical Care Facilities industry and is headquartered in Bangkok, Thailand. Its market capitalization is roughly THB 2 billion. In the fiscal year ended 2025-12-31, KDH reported THB 1.1B in revenue and THB 152M in net income.

Thonburi Medical Centre Public Company Limited operates a hospital in Thailand. The company offers hair center services, such as hair treatment, weight control program, skin and facial treatment, cosmetic surgery, sexual health therapy and special lab clinics; and allergy blood test.

Interactive charts & full statements →

KDH Revenue & Earnings History — Annual Income Statement

Income statement	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Revenue	THB 1.1B	THB 1.0B	THB 1.2B	THB 1.1B	—
Gross Profit	THB 412M	THB 370M	THB 456M	THB 385M	—
Operating Income (EBIT)	THB 183M	THB 168M	THB 128M	THB 103M	—
Net Income	THB 152M	THB 141M	THB 106M	THB 81M	—

THB; THBM / THBB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

KDH Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Total Revenue	THB 277M	THB 282M	THB 305M	THB 284M	THB 265M
Gross Profit	THB 95M	THB 89M	THB 116M	THB 109M	THB 98M
Operating Income (EBIT)	THB 54M	THB 31M	THB 57M	THB 47M	THB 49M
Net Income	THB 47M	THB 26M	THB 47M	THB 39M	THB 41M

THB; THBM / THBB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

KDH Free Cash Flow History

Cash flow	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Dividends Paid	(THB 48M)	(THB 38M)	(THB 14M)	THB 0M	—

THB; THBM / THBB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

KDH Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Dividends Paid	—	THB 0M	THB 0M	—	—	THB 1M

THB; THBM / THBB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

KDH Balance Sheet History

Balance sheet	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Assets	THB 1.1B	THB 1.0B	THB 877M	THB 803M	—
Total Liabilities	THB 209M	THB 213M	THB 173M	THB 189M	—

THB; THBM / THBB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive KDH viewer.

Other Companies in Medical Care Facilities

0708 · China Evergrande New Energy Vehicle Group Limited — HK$2 billion
1830 · Perfect Medical Health Management Limited — HK$2 billion
1526 · Rici Healthcare Holdings Limited — HK$2 billion
2219 · Chaoju Eye Care Holdings Limited — HK$2 billion
HCSG · Healthcare Services Group, Inc. — $2 billion
AGL · agilon health, inc. — $2 billion
ARDT · Ardent Health, Inc. — $2 billion
INNV · InnovAge Holding Corp. — $1 billion

← KDEF All “K” companies KDK →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.